12.5
MSS (Merkezi Sinir Sistemi) Uyarıcıları: Psikedelik Maddeler
Halüsinojenler, aynı zamanda psikedelik ilaçlar olarak bilinen, algı, biliş ve duyguları değiştirme yetenekleriyle tanınan bir madde sınıfıdır. Zihin…
Psychedelic ilaçlar veya halüsinojenler, algıyı, bilişi ve duyguları değiştiren bağımlılık yapmayan maddelerdir.
Beynin 5-HT2A reseptörünü aktive ederler, bu da Gq proteinine bağlanır, IP3 üretir ve sonuçta hücre içi kalsiyum salınımına yol açar.
Halüsinojenler, kendine özgü kimyasal yapılarına göre iki ana sınıfa ayrılır.
İndoleaminler, LSD ve psilosibin gibi ajanları içerir. Duyusal çarpıtmalara, halüsinasyonlara ve değişmiş bilinç durumlarına neden olurlar.
Fenetilaminler, MDMA, meskalin ve PCP gibi ajanları içerir.
Ecstasy veya molly olarak bilinen MDMA, empati ve öfori duygularını ortaya çıkararak hem uyarıcı hem de psychedelic etkiler sağlar.
Başlangıçta bir anestezik olarak geliştirilen PCP, yüksek dozlarda duygusal geri çekilmeye ve saldırganlığa neden oldu.
Halüsinojenler fiziksel bağımlılığa neden olmasalar da, hızlı tolerans gelişimi ilaç takibi veya tıbbi müdahale gerektirir. Bu, hasta güvencesini, şiddetli ajitasyon durumunda diazepam uygulanmasını veya PCP doz aşımı için yaşam desteğini içerir.
View the full transcript and gain access to JoVE Core videos
Q1: How do psychedelic drugs affect the brain at the molecular level?
Psychedelic drugs activate the brain's 5-HT2A receptor, which couples to Gq-type G proteins. This triggers a biochemical cascade that releases intracellular calcium, producing the drugs' distinctive psychological effects. This mechanism underlies the altered perception, cognition, and emotions characteristic of hallucinogens.
Q2: What are the main chemical classes of hallucinogens?
Hallucinogens divide into two classes: indoleamines and phenethylamines. Indoleamines include LSD and psilocybin, producing vivid visual effects and altered consciousness. Phenethylamines include MDMA and PCP, with MDMA providing both stimulant and psychedelic effects, while PCP was originally developed as an anesthetic.
Q3: Why are psychedelic drugs considered non-addictive?
Psychedelic drugs do not cause physical dependence, distinguishing them from many other abused substances. However, rapid tolerance develops with regular use, requiring higher doses to achieve the same effects. While withdrawal symptoms can occur in some users, the absence of physical dependence classifies these drugs as non-addictive.
Q4: What are the distinct effects of MDMA compared to other hallucinogens?
MDMA, known as ecstasy or molly, uniquely provides both stimulant and psychedelic effects. It elicits feelings of empathy, euphoria, and heightened sensory perception. Unlike indoleamines that primarily produce visual distortions, MDMA's dual action creates a distinctive emotional and sensory experience.
Q5: How does PCP differ from other phenethylamines in its effects?
PCP, initially developed as an anesthetic, causes emotional withdrawal and aggressive behavior at high doses. Unlike MDMA, which produces empathy and euphoria, PCP's effects are primarily negative and potentially dangerous. Its anesthetic origins distinguish it chemically and functionally from other phenethylamines.
Q6: What medical interventions are used for hallucinogen overdose or severe reactions?
Treatment involves patient reassurance and administering diazepam for severe agitation. In cases of PCP overdose, life support may be necessary. These interventions address the rapid tolerance and acute psychological effects that can occur, though hallucinogens lack the physical dependence seen in drug abuse and addiction pharmacological phenomena.
Q7: What sensory and psychological effects do indoleamine hallucinogens produce?
Indoleamines like LSD and psilocybin induce sensory distortions, hallucinations, and profoundly altered states of consciousness. These drugs produce vivid visual effects and perceptual changes. Regular use leads to rapid tolerance, requiring higher doses to achieve the same psychological and sensory effects.